NEW YORK – Genomics England is scaling up to support the full launch of the UK National Health Service's Genomic Medicines Service later this year.
The service will provide whole-genome sequencing to English patients with certain rare diseases and cancer as part of routine care, an offering that organizers say is the first of its kind in the world. The launch will also demonstrate Genomics England's transition from a company established to support the 100,000 Genomes Project to a national platform for clinical diagnostics and research.